GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Gross Profit

Galapagos NV (WBO:GLPG) Gross Profit : €241.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV Gross Profit?

Galapagos NV's gross profit for the three months ended in Sep. 2024 was €59.8 Mil. Galapagos NV's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was €241.0 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Galapagos NV's gross profit for the three months ended in Sep. 2024 was €59.8 Mil. Galapagos NV's Revenue for the three months ended in Sep. 2024 was €59.8 Mil. Therefore, Galapagos NV's Gross Margin % for the quarter that ended in Sep. 2024 was 99.97%.

Galapagos NV had a gross margin of 99.97% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Galapagos NV was 206.16%. The lowest was 92.65%. And the median was 205.30%.


Galapagos NV Gross Profit Historical Data

The historical data trend for Galapagos NV's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Gross Profit Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 834.90 478.05 483.22 493.20 239.72

Galapagos NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.16 59.94 59.88 61.32 59.83

Competitive Comparison of Galapagos NV's Gross Profit

For the Biotechnology subindustry, Galapagos NV's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Gross Profit distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Gross Profit falls into.



Galapagos NV Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Galapagos NV's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=239.724 - 0
=239.7

Galapagos NV's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=59.849 - 0.018999999999998
=59.8

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €241.0 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Galapagos NV's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=59.8 / 59.849
=99.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Galapagos NV  (WBO:GLPG) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Galapagos NV had a gross margin of 99.97% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Galapagos NV Gross Profit Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Galapagos NV Headlines